Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
Warmuth Markus sold 5,467 Monte Rosa Therapeutics, Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 5, 2026
On May 1, 2026, Warmuth Markus (Director, President & CEO) sold 5,467 Monte Rosa Therapeutics, Inc. shares at US$18.92 for US$103K under a trading plan, leaving 600,004 shares. Filed May 5, 2026 (Form 4).
- Sold
- 5,467 shares
- Price
- US$18.92
- Value
- US$103K
- Holding after
- 600,004 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Sale | 5,467 | US$18.92 | 600,004 | Direct |
Source
Related
- Monte Rosa Therapeutics, Inc.
- Warmuth Markus
- Monte Rosa Therapeutics, Inc. shareholders
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Warmuth Markus · Jun 2, 2026
- Form 4 · Warmuth Markus · Apr 15, 2026
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Jul 8, 2026